$2.25
0.020.90%
At Close: -
$2.23
-0.02-0.89%
After Hours: Jul 16, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
VYNE Therapeutics
VYNENASDAQ
VYNE Therapeutics (NASDAQ:VYNE) Stock, Earnings Estimates, EPS, And Revenue
VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 12
EPS Estimate
$-0.190
Quarterly Revenue Estimate
$110K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$423K
Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VYNE | VYNE Therapeutics | -$2.82 | -$0.19 | — | — | $135.00K | $110.00K | — | — | 08/12/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$1.48 | -$0.24 | -$0.15 | 37.50% | $99.00K | $100.00K | $98.00K | -2.00% | 05/09/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.97 | -$0.50 | -$0.18 | 64.00% | $6.00K | $150.00K | $76.00K | -49.33% | 02/29/2024 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.52 | -$1.97 | -$1.75 | 11.17% | $167.00K | — | $114.00K | — | 11/13/2023 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.34 | -$1.99 | -$2.82 | -41.71% | $126.00K | $100.00K | $135.00K | 35.00% | 08/14/2023 | Get Alert |
| VYNE | VYNE Therapeutics | $1.80 | -$2.61 | -$1.48 | 43.30% | $178.00K | — | $99.00K | — | 05/11/2023 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.60 | -$3.24 | -$2.97 | 8.33% | $2.29M | $60.00K | $6.00K | -90.00% | 03/09/2023 | Get Alert |
| VYNE | VYNE Therapeutics | -$7.38 | -$3.06 | -$2.52 | 17.65% | $4.09M | $130.00K | $167.00K | 28.46% | 11/10/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$6.30 | -$3.06 | -$2.34 | 23.53% | $4.26M | $100.00K | $126.00K | 26.00% | 08/12/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.96 | -$2.88 | $1.80 | 162.50% | $230.00K | $370.00K | $178.00K | -51.89% | 05/12/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$7.74 | -$4.32 | -$3.60 | 16.67% | $4.29M | $4.12M | $2.29M | -44.37% | 03/17/2022 | Get Alert |
| VYNE | VYNE Therapeutics | -$9.36 | -$5.76 | -$6.48 | -12.50% | $3.27M | $4.76M | $4.09M | -14.16% | 11/10/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.28 | -$6.30 | -$6.30 | 0.00% | $11.69M | $6.21M | $4.26M | -31.43% | 08/12/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.80 | -$7.38 | -$6.66 | 9.76% | — | $5.31M | $4.12M | -22.43% | 05/06/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.56 | -$9.54 | -$7.74 | 18.87% | — | $4.71M | $4.29M | -9.00% | 03/04/2021 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.80 | -$12.24 | -$9.36 | 23.53% | — | $3.25M | $3.27M | 0.58% | 11/05/2020 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.76 | -$1.00 | -$3.28 | -228.00% | — | $2.42M | $11.69M | 382.98% | 08/06/2020 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.24 | -$2.16 | -$3.80 | -75.93% | — | $2.18M | $1.75M | -19.72% | 05/11/2020 | Get Alert |
| VYNE | VYNE Therapeutics | -$3.04 | — | -$3.56 | — | — | — | $0.00 | — | 03/03/2020 | Get Alert |
| VYNE | VYNE Therapeutics | -$2.24 | — | -$2.80 | — | — | — | $0.00 | — | 10/31/2019 | Get Alert |
| VYNE | VYNE Therapeutics | — | -$3.36 | -$2.76 | 17.86% | — | — | $0.00 | — | 08/01/2019 | Get Alert |
VYNE Therapeutics (VYNE) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.15 | $-0.24 | 37.5 % |
| Dec 2023 | 2024-02-29 | $-0.18 | $-0.50 | 64.0 % |
| Sep 2023 | 2023-11-13 | $-1.75 | $-1.97 | 11.2 % |
| Jun 2023 | 2023-08-14 | $-2.82 | $-1.99 | -41.7 % |
VYNE Therapeutics (VYNE) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $98.00K | $100.00K | -2.00 % |
| Dec 2023 | 2024-02-29 | $76.00K | $150.00K | -49.3 % |
| Jun 2023 | 2023-08-14 | $135.00K | $100.00K | 35.0 % |
| Dec 2022 | 2023-03-09 | $6.00K | $60.00K | -90.0 % |
FAQ
When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?
VYNE Therapeutics (VYNE) is scheduled to report earnings on August 12, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for VYNE Therapeutics (NASDAQ:VYNE)?
The Actual EPS was $-0.15, which beat the estimate of $-0.24.
What were VYNE Therapeutics’s (NASDAQ:VYNE) revenues?
The Actual Revenue was $98K, which missed the estimate of $100K.
Browse earnings estimates, EPS, and revenue on all stocks.